ResearchPhase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors
ResearchA Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors
ResearchCorrelates of Cetuximab Efficacy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Previously Treated With Immunotherapy
ResearchEpigenetic Therapy Sensitizes Anti-PD-1 Refractory Head and Neck Cancers to Immunotherapy Rechallenge
ResearchOutcomes for Recurrent or Metastatic Head and Neck Cancer by HPV Status: A Systematic Review and Meta-Analysis
ResearchInterleukin-12 Anchored Drug Conjugate (Tolododekin Alfa) in Patients with Advanced Solid Tumors: First-in-Human Phase 1 Trial
ResearchNivolumab with or without Ipilimumab in Patients with Recurrent or Metastatic Cervical Cancer (CheckMate 358): A Phase 1–2, Open-Label, Multicohort Trial
ResearchFinal Outcomes Analysis of the Cell Product SQZ-PBMC-HPV Phase 1 Trial in Incurable HPV16+ Solid Tumors Shows Improved Overall Survival in Patients with Increased CD8+ T Cell Tumor Infiltration
ResearchSociety for Immunotherapy of Cancer (SITC) Consensus Definitions for Resistance to Combinations of Immune Checkpoint Inhibitors with Chemotherapy